Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Frank O'Brien

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Nature Reviews. Urology|July 7, 2009
Prostate kallikrein markers in diagnosis, risk stratification and prognosisDavid Ulmert, M Frank O'Brien, Anders S Bjartell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2008
Systematic review of pretreatment prostate-specific antigen velocity and doubling time as predictors for prostate cancerAndrew J Vickers, Caroline Savage, M Frank O'Brien, et al.
BJU International|August 27, 2010
Update on the management of T1 renal cortical tumoursMark L Cutress, Hari L Ratan, Simon T Williams, et al.
BJU International|June 4, 2010
Partial nephrectomy for selected renal cortical tumours of ≥ 7 cmMichael E Karellas, M Frank O'Brien, Thomas L Jang, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|January 19, 2017
The impact of day of surgery on the length of stay for major urological proceduresGregory J Nason, Eabhann M O'Connor, Cathleen O'Neill, et al.
Irish Journal of Medical Science|December 7, 2010
Is simple nephrectomy truly simple? Comparison with the radical alternativeS S Connolly, M Frank O'Brien, I M Kunni, et al.
International Journal of Cancer|March 7, 2013
Association of cancer with moderately impaired renal function at baseline in a large, representative, population-based cohort followed for up to 30 yearsAnders Christensson, Caroline Savage, Daniel D Sjoberg, et al.
The Journal of Urology|July 21, 2010
Prostate specific antigen velocity does not aid prostate cancer detection in men with prior negative biopsyAndrew J Vickers, Tineke Wolters, Caroline J Savage, et al.
European Urology|August 18, 2009
Prostate-specific antigen velocity for early detection of prostate cancer: result from a large, representative, population-based cohortAndrew J Vickers, Tineke Wolters, Caroline J Savage, et al.
International Journal of Cancer|July 27, 2010
Evaluation of prediagnostic prostate-specific antigen dynamics as predictors of death from prostate cancer in patients treated conservativelyM Frank O'Brien, Angel M Cronin, Paul A Fearn, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Nature Reviews. Urology|July 7, 2009
Prostate kallikrein markers in diagnosis, risk stratification and prognosisDavid Ulmert, M Frank O'Brien, Anders S Bjartell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2008
Systematic review of pretreatment prostate-specific antigen velocity and doubling time as predictors for prostate cancerAndrew J Vickers, Caroline Savage, M Frank O'Brien, et al.
BJU International|August 27, 2010
Update on the management of T1 renal cortical tumoursMark L Cutress, Hari L Ratan, Simon T Williams, et al.
BJU International|June 4, 2010
Partial nephrectomy for selected renal cortical tumours of ≥ 7 cmMichael E Karellas, M Frank O'Brien, Thomas L Jang, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|January 19, 2017
The impact of day of surgery on the length of stay for major urological proceduresGregory J Nason, Eabhann M O'Connor, Cathleen O'Neill, et al.
Irish Journal of Medical Science|December 7, 2010
Is simple nephrectomy truly simple? Comparison with the radical alternativeS S Connolly, M Frank O'Brien, I M Kunni, et al.
International Journal of Cancer|March 7, 2013
Association of cancer with moderately impaired renal function at baseline in a large, representative, population-based cohort followed for up to 30 yearsAnders Christensson, Caroline Savage, Daniel D Sjoberg, et al.
The Journal of Urology|July 21, 2010
Prostate specific antigen velocity does not aid prostate cancer detection in men with prior negative biopsyAndrew J Vickers, Tineke Wolters, Caroline J Savage, et al.
European Urology|August 18, 2009
Prostate-specific antigen velocity for early detection of prostate cancer: result from a large, representative, population-based cohortAndrew J Vickers, Tineke Wolters, Caroline J Savage, et al.
International Journal of Cancer|July 27, 2010
Evaluation of prediagnostic prostate-specific antigen dynamics as predictors of death from prostate cancer in patients treated conservativelyM Frank O'Brien, Angel M Cronin, Paul A Fearn, et al.
Pageof 1